Inactive Instrument

nanosynth group plc

Equities

AERO

GB00BFX0ZN92

Biotechnology & Medical Research

Nanosynth Group Plc Announces Update on Distribution Agreement with Vivek Kohli Enterprises OPC Private Ltd

August 27, 2021 at 06:00 pm IST

The Board of nanosynth notes commentary in relation to its distribution agreement with Vivek Kohli Enterprises OPC Private Ltd. ("VKE"), and in particular that VKE considers that such partnership could generate over £17 million in revenue.

Latest news about nanosynth group plc

EARNINGS AND TRADING: nanosynth shares remain suspended on AIM	03/23/03	AN
Nanosynth CFO Andrew Stedman steps down with immediate effect	30/23/30	AN
Nanosynth Announces Resignation of Andrew Stedman as Chief Financial Officer	30/23/30	CI
Jardine Matheson net assets rise, Oberon loss widens	28/23/28	AN
Nanosynth group plc Announces Executive Changes	28/23/28	CI
Nanosynth group plc Announces Resignation of Mark Duffin from the Board	28/23/28	CI
WANDisco in extra cost savings; SRT raises GBP750,000	27/23/27	AN
Trinity Exploration spuds well; Equipmake inks deal	17/23/17	AN
UK nanotech firm Nanosynth proposes to enter voluntary liquidation	16/23/16	RE
Nanosynth Plans Voluntary Liquidation; London Shares Surge Before Trading Halt	16/23/16	MT
Nanosynth shares plummet on lack of cash resources	06/23/06	AN
Nanosynth Group plc Announces Resignation of Richard Clarke as Chairman, Effective on April 7, 2023	26/23/26	CI
TRADING UPDATES: Future Metals in JV; Gunsynd sells stake in investee	18/23/18	AN
FTSE 100 Closed Down 0.4% Amid World Bank Recession Warning	10/23/10	DJ
BOE Could Start Cutting the Bank Rate in 4Q 2023, Says UBS	10/23/10	DJ
Retail Prospects Are Encouraging Given Better-Than-Feared Christmas	10/23/10	DJ
Nanosynth shares plunge on GBP400,000 discounted placing	10/23/10	AN
January 2033 Gilt Looks Less Attractive Ahead of Auction	10/23/10	DJ
FTSE 100 Drops as RS Group Falls; Retailers Gain	10/23/10	DJ
Earnings Flash (NNN.L) NANOSYNTH GROUP Reports H1 Loss GBX-0.09	30/22/30	MT
Earnings Flash (NNN.L) NANOSYNTH GROUP Posts H1 Revenue GBP9,988	30/22/30	MT
Nanosynth group plc Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30	CI
Nanosynth Group Surges 20% After Successful Trial Of Anti-viral Technology For Air Systems	31/22/31	MT
Nanosynth Group plc Announces Successful Trial Results with Volz Holdings V.O.S to Enable Both Companies to Develop A Standard Retro-Fit to Media Production Lines	31/22/31	CI
Nanosynth To Jointly Develop Product For Cosmetics Market	30/22/30	MT

Chart nanosynth group plc

Duration

Period

More charts

Company Profile

nanosynth group plc is a United Kingdom-based nano-technology business that originated in Nottingham from a partnership with Nottingham Trent University. The Company specializes in the synthesis and application of nanoparticles to create new and improve existing products. The Company is focused on developing commercial applications to enhance existing products and to develop new products, leveraging its platform nanotechnology and material science across a range of industry sectors and markets. It uses patented technology to reproducibly synthesize and functionalize nanoparticles that are homogenous. Its technology developed at Nottingham Trent University, uses a spinning disk reactor to control both the size and shape of the nanoparticles, making its process efficient and scalable for a variety of applications. The Company has two operating subsidiaries, Nanovate Ltd and Virosynth Ltd, each of which is focused on specific industry applications of the core technology.

Sector

Biotechnology & Medical Research

Calendar

26/06/2024 - Q4 2023 Earnings Release (Projected)

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+41.79%	5.09TCr
IQVIA HOLDINGS INC.	-0.56%	4.21TCr
LONZA GROUP AG	+49.62%	4.2TCr
CELLTRION, INC.	-7.20%	2.92TCr
ICON PUBLIC LIMITED COMPANY	+12.59%	2.6TCr
ALNYLAM PHARMACEUTICALS, INC.	-21.51%	1.89TCr
BIO-TECHNE CORPORATION	+6.92%	1.32TCr
UNITED THERAPEUTICS CORPORATION	+24.91%	1.22TCr
MEDPACE HOLDINGS, INC.	+29.60%	1.22TCr

Other Biotechnology & Medical Research